TVRD

Tvardi Therapeutics
TVRD

33 hedge funds and large institutions have $3.21M invested in Tvardi Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 12 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$135K
2
+$55.9K
3
+$10.1K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.54K
5
JP Morgan Chase
JP Morgan Chase
New York
+$471

Top Sellers

1
-$953K
2
-$721K
3
-$524K
4
CRC
Curi RMB Capital
Illinois
-$277K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$852K
2
$658K
3
$449K
4
$314K
5
$249K
6
$200K
7
$137K
8
$96.8K
9
$88.3K
10
$75.5K
11
$61.6K
12
$13.2K
13
$7.48K
14
$5.65K
15
$1.26K
16
$672
17
$339
18
$309
19
$243
20
$237
21
$223
22
$218
23
$213
24
$177
25
$153
1
2